[KSCI] Korea Science Citation Index Service

http://dx.doi.org/10.14348/molcells.2016.2288

Identification of Genetic Causes of Inherited Peripheral Neuropathies by Targeted Gene Panel Sequencing

Nam, Soo Hyun (Department of Biological Sciences, Kongju National University)
Hong, Young Bin (Stem Cell & Regenerative Medicine Center and Neuroscience Center, Samsung Medical Center)
Hyun, Young Se (Department of Biological Sciences, Kongju National University)
Nam, Da Eun (Department of Biological Sciences, Kongju National University)
Kwak, Geon (Department of Neurology, Sungkyunkwan University School of Medicine)
Hwang, Sun Hee (Department of Neurology, Sungkyunkwan University School of Medicine)
Choi, Byung-Ok (Stem Cell & Regenerative Medicine Center and Neuroscience Center, Samsung Medical Center)
Chung, Ki Wha (Department of Biological Sciences, Kongju National University)

Abstract

Inherited peripheral neuropathies (IPN), which are a group of clinically and genetically heterogeneous peripheral nerve disorders including Charcot-Marie-Tooth disease (CMT), exhibit progressive degeneration of muscles in the extremities and loss of sensory function. Over 70 genes have been reported as genetic causatives and the number is still growing. We prepared a targeted gene panel for IPN diagnosis based on next generation sequencing (NGS). The gene panel was designed to detect mutations in 73 genes reported to be genetic causes of IPN or related peripheral neuropathies, and to detect duplication of the chromosome 17p12 region, the major genetic cause of CMT1A. We applied the gene panel to 115 samples from 63 non-CMT1A families, and isolated 15 pathogenic or likelypathogenic mutations in eight genes from 25 patients (17 families). Of them, eight mutations were unreported variants. Of particular interest, this study revealed several very rare mutations in the SPTLC2, DCTN1, and MARS genes. In addition, the effectiveness of the detection of CMT1A was confirmed by comparing five 17p12-nonduplicated controls and 15 CMT1A cases. In conclusion, we developed a gene panel for one step genetic diagnosis of IPN. It seems that its time- and cost-effectiveness are superior to previous tiered-genetic diagnosis algorithms, and it could be applied as a genetic diagnostic system for inherited peripheral neuropathies.

Keywords

charcot-Marie-Tooth disease (CMT); DCTN1; gene panel; inherited peripheral neuropathy; MARS; SPTLC2;

Citations & Related Records

Times Cited By KSCI : 2 (Citation Analysis)

Reference
Cited By KSCI

1	Antoniadi, T., Buxton, C., Dennis, G., Forrester, N., Smith, D., Lunt, P., and Burton-Jones, S. (2015). Application of targeted multigene panel testing for the diagnosis of inherited peripheral neuropathy provides a high diagnostic yield with unexpected phenotype-genotype variability. BMC Med. Genet. 16, 84.
2	Bone, L.J., Deschenes, S.M., Balice-Gordon, R.J., Fischbeck, K.H., and Scherer, S.S. (1997). Connexin32 and X-linked Charcot-Marie-Tooth disease. Neurobiol. Dis. 4, 221-230. DOI
3	Choi, B.O., Kim, J., Lee, K.L., Yu, J.S., Hwang, J.H., and Chung, K.W. (2007). Rapid diagnosis of CMT1A duplications and HNPP deletions by multiplex microsatellite PCR. Mol. Cells 23, 39-48.
4	Choi, B.O., Koo, S.K., Park, M.H., Rhee, H., Yang, S.J., Choi, K.G., Jung, S.C., Kim, H.S., Hyun, Y.S., Nakhro, K., et al. (2012). Exome sequencing is an efficient tool for genetic screening of Charcot-Marie-Tooth disease. Hum. Mutat. 33, 1610-1615. DOI
5	Choi, B.O., Nakhro, K., Park, H.J., Hyun, Y.S., Lee, J.H., Kanwal, S., Jung, S.C., and Chung, K.W. (2015). A cohort study of MFN2 mutations and phenotypic spectrums in Charcot-Marie-Tooth disease 2A patients. Clin. Genet. 87, 594-598. DOI
6	Chung, K.W., Kim, S.B., Park, K.D., Choi, K.G., Lee, J.H., Eun, H.W., Suh, J.S., Hwang, J.H., Kim, W.K., Seo, B.C., et al. (2006). Early onset severe and late-onset mild Charcot-Marie-Tooth disease with mitofusin 2 (MFN2) mutations. Brain 129, 2103-2118. DOI
7	Drew, A.P., Zhu, D., Kidambi, A., Ly, C., Tey, S., Brewer, M.H., Ahmad-Annuar, A., Nicholson, G.A., and Kennerson, M.L. (2015). Improved inherited peripheral neuropathy genetic diagnosis by whole-exome sequencing. Mol. Genet. Genomic Med. 3, 143-154. DOI
8	Ernst, D., Murphy, S.M., Sathiyanadan, K., Wei, Y., Othman, A., Laura, M., Liu, Y.T., Penno, A., Blake, J., Donaghy, M., et al. (2015). Novel HSAN1 mutation in serine palmitoyltransferase resides at a putative phosphorylation site that is involved in regulating substrate specificity. Neuromolecular Med. 17, 47-57. DOI
9	Gonzaga-Jauregui, C., Harel, T., Gambin, T., Kousi, M., Griffin, L.B., Francescatto, L., Ozes, B., Karaca, E., Jhangiani, S.N., Bainbridge, M.N., et al. (2015). Exome sequence analysis suggests that genetic burden contributes to phenotypic variability and complex neuropathy. Cell Rep. 12, 1169-1183 DOI
10	Gonzalez, M., McLaughlin, H., Houlden, H. Guo, M., Yo-Tsen, L., Hadjivassilious, M., Speziani, F., Yang, X.L., Antonellis, A., Reilly, M.M., et al. (2013). Exome sequencing identifies a significant variant in methionyl-tRNA synthetase (MARS) in a family with late-onset CMT2. J. Neurol. Neurosurg. Psychiatry 84, 1247-1249. DOI
11	Hyun, Y.S., Park, H.J., Heo, S.H., Yoon, B.R., Nam, S.H., Kim, S.B., Park, C.I., Choi, B.O., and Chung, K.W. (2014). Rare variants in methionyl- and tyrosyl-tRNA synthetase genes in late-onset autosomal dominant Charcot-Marie-Tooth neuropathy. Clin. Genet. 86, 592-594. DOI
12	Lupski, J.R., and Garcia, C.A. (2000). Charcot-Marie-Tooth peripheral neuropathies and related disorders. In the metabolic and molecular bases of inherited disease. Vol. 4. 8th, C.R. Scriver, ed. (New York, Mc Graw Hill), pp. 5759-5788.
13	Nelis, E., Van Broeckhoven, C., De Jonghe, P., Lofgren, A., Vandenberghe, A., Latour, P., Le Guern, E., Brice, A., Mostacciuolo, M.L., Schiavon, F., et al. (1996). Estimation of the mutation frequencies in Charcot-Marie-Tooth disease type 1 and hereditary neuropathy with liability to pressure palsies: a European collaborative study. Eur. J. Hum. Genet. 4, 25-33. DOI
14	Montenegro, G., Powell, E., Huang, J. Speziani, F., Edwards, Y.J., Beecham, G., Hulme, W., Siskind, C., Vance, J., Shy, M., et al. (2011). Exome sequencing allows for rapid gene identification in a Charcot-Marie-Tooth family. Ann. Neurol. 69, 464-470. DOI
15	Murphy, S.M., Laura, M., and Reilly, M.M. (2013). DNA testing in hereditary neuropathies. Handb. Clin. Neurol. 115, 213-232. DOI
16	Nakhro, K., Park, J.M., Choi, B.O., and Chung, K.W. (2013). Missense mutations of mitofusin 2 in axonal Charcot-Marie-Tooth neuropathy: polymorphic or incomplete penetration?. Anim. Cells Syst. 17, 228-236. DOI
17	Oterino, A., Monton, F.I., Cabrera, V.M., Pinto, F., Gonzalez, A., and Lavilla, N.R. (1996). Arginine-164-tryptophan substitution in connexin32 associated with X linked dominant Charcot-Marie-Tooth disease. J. Med. Genet. 33, 413-415. DOI
18	Patzko, A., and Shy, M.E. (2011). Update on Charcot-Marie-Tooth disease. Curr. Neurol. Neurosci. Rep. 11, 78-88. DOI
19	Puls, I., Jonnakuty, C., LaMonte, B.H., Holzbaur, E.L., Tokito, M., Mann, E., Floeter, M.K., Bidus, K., Drayna, D., Oh, S.J., et al. (2003). Mutant dynactin in motor neuron disease. Nat. Genet. 33, 455-456. DOI
20	Rossor, A.M., Polke, J.M., Houlden, H., and Reilly, M.M. (2013). Clinical implications of genetic advances in Charcot-Marie-Tooth disease. Nat. Rev. Neurol. 9, 562-571. DOI
21	Schiavon, F., Fracasso, C., and Mostacciuolo, M.L. (1996). Novel missense mutation of the connexin32 (GJB1) gene in X-linked dominant Charcot-Marie-Tooth neuropathy. Hum. Mutat. 8, 83-84. DOI
22	Rotthier, A., Auer-Grumbach, M., Janssens, K., Baets, J., Penno, A., Almeida-Souza, L., Van Hoof, K., Jacobs, A., De Vriendt, E., Schlotter-Weigel, B., et al. (2010). Mutations in the SPTLC2 subunit of serine palmitoyltransferase cause hereditary sensory and autonomic neuropathy type I. Am. J. Hum. Genet. 87, 513-522. DOI
23	Rudnik-Schoneborn, S., Tolle, D., Senderek, J., Eggermann, K., Elbracht, M., Kornak, U., von der Hagen, M., Kirschner, J., Leube, B., Muller-Felber, W., et al. (2016). Diagnostic algorithms in Charcot-Marie-Tooth neuropathies: experiences from a German genetic laboratory on the basis of 1206 index patients. Clin. Genet. 89, 34-43. DOI
24	Saporta, A.S., Sottile, S.L., Miller, L.J., Feely, S.M., Siskind, C.E., and Shy, M.E. (2011). Charcot-Marie-Tooth disease subtypes and genetic testing strategies. Ann. Neurol. 69, 22-33. DOI
25	Sinkiewicz-Darol, E., Lacerda, A.F., Kostera-Pruszczyk, A., Potulska-Chromik, A., Sokolowska, B., Kabzinska, D., Brunetti, C.R., Hausmanowa-Petrusewicz, I., and Kochanski, A. (2015). The LITAF/SIMPLE I92V sequence variant results in an earlier age of onset of CMT1A/HNPP diseases. Neurogenetics 16, 27-32. DOI
26	Ylikallio, E., Johari, M., Konovalova, S., Moilanen, J.S., Kiuru-Enari, S., Auranen, M., Pajunen, L., and Tyynismaa, H. (2014). Targeted next-generation sequencing reveals further genetic heterogeneity in axonal Charcot-Marie-Tooth neuropathy and a mutation in HSPB1. Eur. J. Hum. Genet. 22, 522-527. DOI

	Da Hye Yoo. (2017) Mitochondrion Identification of FASTKD2 compound heterozygous mutations as the underlying cause of autosomal recessive MELAS-like syndrome / 35 , 54
	Takuya Konno. (2017) Parkinsonism & Related Disorders DCTN1 -related neurodegeneration: Perry syndrome and beyond / 41 , 14
7	Jee Young Kim. (2016) Genes & Genomics Genotype–phenotype correlation of Charcot-Marie-Tooth type 1E patients with PMP22 mutations / 38 (7) , 659
9	Erik Storkebaum. (2016) BioEssays Peripheral neuropathy via mutant tRNA synthetases: Inhibition of protein translation provides a possible explanation / 38 (9) , 818
	Alexander M. Rossor. (2016) Current Opinion in Neurology Recent advances in the genetic neuropathies / , 1
4	Makito Hirano. (2016) Journal of the Peripheral Nervous System Histopathological features of a patient with Charcot-Marie-Tooth disease type 2U/AD-CMTax-MARS / 21 (4) , 370
	Li-Xi Li. (2017) Human Mutation Identification and functional characterization of two missense mutations in NDRG1 associated with Charcot-Marie-Tooth disease type 4D /
4	Chi-Chun Ho. (2017) International Journal of Molecular Sciences Rapid Identification of Pathogenic Variants in Two Cases of Charcot-Marie-Tooth Disease by Gene-Panel Sequencing / 18 (4) , 770
3	Young B. Hong. (2017) Journal of the Peripheral Nervous System Clinical characterization and genetic analysis of Korean patients with X-linked Charcot-Marie-Tooth disease type 1 / 22 (3) , 172
3	(2017) Human Mutation Substrate interaction defects in histidyl-tRNA synthetase linked to dominant axonal peripheral neuropathy / 39 (3) , 415
2	(2017) Journal of Neuropathology & Experimental Neurology Nerve Biopsy Is Still Useful in Some Inherited Neuropathies / 77 (2) , 88
2	(2018) Journal of Neurology, Neurosurgery & Psychiatry Genetic profile and onset features of 1005 patients with Charcot-Marie-Tooth disease in Japan / 90 (2) , 195
5	(2016) Expert opinion on orphan drugs Perry disease: recent advances and perspectives / 7 (5) , 253
1	(2018) Journal of the Peripheral Nervous System ) mutation in an axonal Charcot-Marie-Tooth disease family / 23 (1) , 60
1	(2018) Genes & Genomics Wide phenotypic spectrum in axonal Charcot–Marie–Tooth neuropathy type 2 patients with KIF5A mutations / 40 (1) , 77
10859489	(2018) Journal of the Peripheral Nervous System Clinical and genetic investigation in Chinese patients with demyelinating Charcot-Marie-Tooth disease / (10859489)
36	(2018) World Journal of Gastroenterology Novel methionyl-tRNA synthetase gene variants/phenotypes in interstitial lung and liver disease: A case report and review of literature / 24 (36) , 4208
2	(2018) Journal of the Peripheral Nervous System gene related to a rare Charcot-Marie-Tooth neuropathy type 2U / 23 (2) , 138
3	(2016) Current medicinal chemistry NGS Technologies as a Turning Point in Rare Disease Research, Diagnosis and Treatment / 25 (3) , 404
5	(2018) Journal of neurology, neurosurgery, and psychiatry Establishing diagnostic criteria for Perry syndrome / 89 (5) , 482
14	(2016) International journal of molecular sciences Charcot-Marie-Tooth: From Molecules to Therapy / 20 (14) , 3419
9	(2019) Genes & genomics Zebrafish is a central model to dissect the peripheral neuropathy / 41 (9) , 993
9	(2016) Journal of human genetics Compound heterozygous mutations of SH3TC2 in Charcot-Marie-Tooth disease type 4C patients / 64 (9) , 961
3	(2016) Journal of neuromuscular diseases A Novel Mutation in MARS in a Patient with Charcot-Marie-Tooth Disease, Axonal, Type 2U with Congenital Onset / 6 (3) , 333
11	(2019) Nature reviews. Neurology Next-generation sequencing in Charcot-Marie-Tooth disease: opportunities and challenges / 15 (11) , 644
4	(2016) Journal of the peripheral nervous system : JPNS Yield of next‐generation neuropathy gene panels in axonal neuropathies / 24 (4) , 324
4	(2016) Molecular genetics & genomic medicine Whole exome sequencing establishes diagnosis of Charcot-Marie-Tooth 4J, 1C, and X1 subtypes / 8 (4) , None
6	(2020) Genes & genomics Alanyl-tRNA synthetase 1 (AARS1) gene mutation in a family with intermediate Charcot-Marie-Tooth neuropathy / 42 (6) , 663
2	(2020) Neurogenetics Whole exome sequencing reveals a broader variant spectrum of Charcot-Marie-Tooth disease type 2 / 21 (2) , 79
3	(2016) Journal of neurochemistry Aminoacyl‐tRNA synthetases in Charcot–Marie–Tooth disease: A gain or a loss? / 157 (3) , 351
6	(2021) Molecular genetics & genomic medicine Genetic and clinical spectrums in Korean Charcot‐Marie‐Tooth disease patients with myelin protein zero mutations / 9 (6) , None
6559	(2021) Science tRNA overexpression rescues peripheral neuropathy caused by mutations in tRNA synthetase / 373 (6559) , 1161
11	(2021) European journal of neurology : the official journal of the European Federation of Neurological Societies Genotype and phenotype distribution of 435 patients with Charcot–Marie–Tooth disease from central south China / 28 (11) , 3774
4	(2016) Muscle & nerve Diagnostic yield of advanced genetic testing in patients with hereditary neuropathies: A retrospective single‐site study / 64 (4) , 454